Secondary Hodgkin Lymphoma and Myelodysplastic Syndrome (MDS) After Paclitaxel-Carboplatin Treatment in a Patient with Small Cell Lung Cancer

1. Karim SM, Zekri J. Chemotherapy for small cell lung cancer: a comprehensive review. Oncol Rev 2012;6:16-36.10.4081/oncol.2012.e4Search in Google Scholar

2. Yeasmin S, Nakayama K, Ishibashi M, Oride A, Katagiri A, Purwana IN, Iida K, Nakayama N, Ishikura H, Miyazaki K. Therapy-related myelodysplasia and acute myeloid leukemia following paclitaxel- and carboplatin-based chemotherapy in an ovarian cancer patient: a case report and literature review. Int J Gynecol Cancer 2008;18(6):1371-6.10.1111/j.1525-1438.2007.01185.x18217963Open DOISearch in Google Scholar

3. Wolf S, Barton D, Kottschade L, Grothey A, Loprinzi C. Chemotherapy-induced peripheral neuropathy: Prevention and treatment strategies. Eur J Cancer 2008;44:1507-15.10.1016/j.ejca.2008.04.01818571399Search in Google Scholar

4. Koklu H, Tufan A, Erkul Y, Akyurek N, Civelek R. Secondary acute myeloid leukemia arising early after cyclophosphamide treatment. Int J Clin Pharm 2015;37(2):289-91.10.1007/s11096-015-0069-425612567Search in Google Scholar

5. See HT, Thomas DA, Bueso-Ramos C, Kavanagh J. Secondary leukemia after treatment with paclitaxel and carboplatin in a patient with recurrent ovarian cancer. Int J Gynecol Cancer 2006;16:236-40.10.1111/j.1525-1438.2006.00491.x16515597Open DOISearch in Google Scholar

6. Bhatia S. Therapy-related myelodysplasia and acute myeloid leukemia. Semin Oncol. 2013; 40(6):10-2410.1053/j.seminoncol.2013.09.013386774324331189Open DOISearch in Google Scholar

7. Gajendra A, Sharma A, Sharma R, Gupta SK, Sood N, Sachdev R. Hodkin Lymphoma in a case of chronic myeloid leukemia treated with tyrosine kinase inhibitors. Turk Patoloji Derg 2017; (ahead of print).10.5146/tjpath.2016.0136828272671Search in Google Scholar

8. Lucy A. Godley, Richard A. Larson. Therapy-related Myeloid Leukemia. Semin Oncol 2008;35(4):418–29.10.1053/j.seminoncol.2008.04.012260044518692692Search in Google Scholar

9. Armitage JO, Carbone PP, Connors JM, Levine A, Bennett JM, Kroll S. Treatment-related myelodysplasia and acute leukemia in non-Hodgkin’s lymphoma patients. J Clin Oncol 2003;21(5):897-906.10.1200/JCO.2003.07.11312610191Open DOISearch in Google Scholar

10. Pinheiro RF, Chauffaille ML. Myelodysplastic syndrome secondary to chemotherapy or radiotherapy - treatment-related MDS. Rev Bras Hematol Hemoter 2006;28(3):201-3.10.1590/S1516-84842006000300010Search in Google Scholar

11. Pedersen-Bjergaard J, Andersen MK, Andersen MT, Christiansen DH. Genetics of therapy-related myelodysplasia and acute myeloid leukemia. Leukemia 2008;22: 240–810.1038/sj.leu.240507818200041Search in Google Scholar

12. Seymour JF, Juneja SK, Campbell LJ, Ellims PH, Estey EH, Prince HM. Secondary acute myeloid leukemia with inv(16): report of two cases following paclitaxel-containing chemotherapy and review of the role of intensified ara-C therapy. Leukemia 1999;13(11):1735-40.10.1038/sj.leu.240155210557046Search in Google Scholar

13. Tasaka T, Matsuhashi Y, Uehara E, Tamura T, Kakazu N, Abe T, Nagai M. Secondary acute monocytic leukemia with a translocation t(8;16) (p11;p13): case report and review of the literature. Leuk Lymphoma 2004;45(3):621-5.10.1080/1042819031000159305815160929Search in Google Scholar

14. Ishikawa M, Nakayama K, Rahman MT, Rahman M, Katagiri H, Katagiri A, Ishibashi T, Iida K, Nakayama N, Miyazaki K. Therapy-related myelodysplastic syndrome and acute myeloid leukemia following chemotherapy (paclitaxel and carboplatin) and radiation therapy in ovarian cancer: a case report. Eur J Gynaec Oncol 2014;35(4):443-8.Search in Google Scholar

15. Takagi H, Ichigo S, Matsunami K, Takagi H, Ikeda T, Murase T, Imai A. Occurrence of myelodysplastic syndrome during paclitaxel and carboplatin-based chemotherapy for recurrent ovarian cancer: Case report. Open J Obst Gynec 3:232-4.10.4236/ojog.2013.32043Search in Google Scholar

16. Noronha V, Berliner N, Ballen KK, Lacy J, Kracher J, Baehring J, Henson JW. Treatment-related my elodysplasia/AML in a patient with a history of breast cancer and an oligodendroglioma treated with temozolomide: Case study and review of the literature. Neuro-oncol 2006;8(3):280–3.10.1215/15228517-2006-003187195016728498Search in Google Scholar

17. Kumar CC. Genetic Abnormalities and Challenges in the Treatment of Acute Myeloid Leukemia. Genes Cancer 2011;2(2):95–107.10.1177/1947601911408076311124521779483Search in Google Scholar

18. Josting A, Wiedenmann S, Franklin J, May M, Sieber M, Wolf J, Engert A, Diehl V. Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin’s disease: a report from the German Hodgkin’s lymphoma study group. J Clin Oncol 2003;21(18):3440-6.10.1200/JCO.2003.07.16012668650Search in Google Scholar

19. Ng AK, Patricia Bernardo MV, Weller E, Backstrand K, Silver B, Marcus KC, Tarbell NJ, Stevenson MA, Friedberg JW, Mauch PM. Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors. Blood 2002;100:1989-96.10.1182/blood-2002-02-063412200357Search in Google Scholar

20. Groen HJ, Fokkema E, Biesma B, Kwa B, van Putten JW, Postmus PE, Smit EF. Paclitaxel and carboplatin in the treatment of small-cell lung cancer patients resistant to cyclophosphamide, doxorubicin, and etoposide: a non-cross-resistant schedule. J Clin Oncol 1999;17(3):927-32.10.1200/JCO.1999.17.3.92710071286Open DOISearch in Google Scholar